Article
Colorectal Cancer Drug Approved on 'Fast Track'
Author(s):
12 AUGUST ? After its fastest review yet for a cancer drug, FDA has approved the colorectal cancer drug Eloxatin (oxaliplatin).
Colorectal Cancer Drug Approved on 'Fast Track'—After its fastest review yet for a cancer drug, FDA has approved thecolorectal cancer drug Eloxatin (oxaliplatin). Used in combination withother cancer drugs, the drug was shown to shrink tumors in some patients anddelay resumed tumor growth.http://www.fda.gov/bbs/topics/NEWS/2002/NEW00825.html
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Videos
Related Content
